Bartlett & Co. Wealth Management LLC Abbott Laboratories Transaction History

Bartlett & Co. Wealth Management LLC

$6.97 Trillion
Q3 2024

A detailed history of Bartlett & Co. Wealth Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 1,071,941 shares of ABT stock, worth $123 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

1,071,941

Previous 1,081,142 0.85%

Holding current value

$123 Million

Previous $112 Billion 8.79%

% of portfolio

1.75%

Previous 1.7%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$100.07 - $118.13 $920,744 - $1.09 Million	-9,201 Reduced 0.85%	1,071,941 $122 Billion
Q2 2024 Jul 12, 2024	SELL	$100.73 - $112.44 $1.94 Million - $2.17 Million	-19,276 Reduced 1.75%	1,081,142 $112 Billion
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $654,272 - $722,615	5,974 Added 0.55%	1,100,418 $125 Billion
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $652,163 - $798,302	7,231 Added 0.67%	1,094,444 $121 Billion
Q3 2023 Feb 14, 2024	BUY	$95.53 - $114.62 $1.51 Million - $1.82 Million	15,856 Added 1.48%	1,087,213 $105 Billion
Q2 2023 Feb 14, 2024	BUY	$100.78 - $112.29 $4.08 Million - $4.55 Million	40,506 Added 3.93%	1,071,357 $117 Billion
Q1 2023 Feb 14, 2024	SELL	$96.86 - $114.01 $366,033 - $430,843	-3,779 Reduced 0.37%	1,030,851 $104 Billion
Q4 2022 Feb 14, 2024	BUY	$95.06 - $111.52 $135,745 - $159,250	1,428 Added 0.14%	1,034,630 $114 Billion
Q3 2022 Feb 14, 2024	BUY	$96.76 - $112.03 $225,160 - $260,693	2,327 Added 0.23%	1,033,202 $100 Billion
Q2 2022 Feb 14, 2024	SELL	$102.07 - $123.37 $766,443 - $926,385	-7,509 Reduced 0.72%	1,030,875 $112 Billion
Q1 2022 Feb 14, 2024	BUY	$114.02 - $139.04 $1.65 Million - $2.01 Million	14,465 Added 1.41%	1,038,384 $123 Billion
Q4 2021 Feb 14, 2024	SELL	$115.53 - $141.46 $252,895 - $309,655	-2,189 Reduced 0.21%	1,023,919 $144 Billion
Q3 2021 Feb 13, 2024	SELL	$116.66 - $129.06 $451,124 - $499,075	-3,867 Reduced 0.38%	1,026,108 $121 Billion
Q2 2021 Feb 13, 2024	BUY	$105.79 - $124.53 $729,739 - $859,007	6,898 Added 0.67%	1,029,975 $119 Billion
Q1 2021 Feb 13, 2024	SELL	$108.84 - $128.23 $578,593 - $681,670	-5,316 Reduced 0.52%	1,023,077 $123 Billion
Q4 2020 Feb 13, 2024	BUY	$105.0 - $114.42 $3,150 - $3,432	30 Added 0.0%	1,028,393 $113 Billion
Q3 2020 Feb 13, 2024	SELL	$91.64 - $111.29 $99,337 - $120,638	-1,084 Reduced 0.11%	1,028,363 $112 Billion
Q2 2020 Feb 13, 2024	BUY	$76.57 - $98.0 $163,094 - $208,740	2,130 Added 0.21%	1,029,447 $94.1 Billion
Q1 2020 Feb 13, 2024	SELL	$62.82 - $91.86 $820,052 - $1.2 Million	-13,054 Reduced 1.25%	1,027,317 $81.1 Billion
Q4 2019 Feb 13, 2024	SELL	$78.51 - $87.4 $561,267 - $624,822	-7,149 Reduced 0.68%	1,040,371 $90.4 Billion
Q3 2019 Feb 13, 2024	BUY	$81.84 - $88.74 $21.2 Million - $23 Million	259,093 Added 32.86%	1,047,520 $87.6 Billion
Q2 2019 Feb 13, 2024	SELL	$72.88 - $85.0 $481,153 - $561,170	-6,602 Reduced 0.83%	788,427 $66.3 Billion
Q1 2019 Feb 13, 2024	SELL	$66.22 - $80.06 $801,063 - $968,485	-12,097 Reduced 1.5%	795,029 $63.6 Billion
Q4 2018 Feb 13, 2024	SELL	$65.56 - $74.27 $1.18 Million - $1.33 Million	-17,966 Reduced 2.18%	807,126 $58.4 Billion
Q3 2018 Feb 13, 2024	SELL	$60.81 - $73.36 $2.98 Million - $3.6 Million	-49,018 Reduced 5.61%	825,092 $60.5 Billion
Q2 2018 Feb 13, 2024	SELL	$57.57 - $63.54 $268,621 - $296,477	-4,666 Reduced 0.53%	874,110 $53.3 Billion
Q1 2018 Feb 13, 2024	BUY	$56.27 - $63.62 $49.4 Million - $55.9 Million	878,776 New	878,776 $52.7 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.

Account

Bartlett & Co. Wealth Management LLC Abbott Laboratories Transaction History